Clorox (NYSE:CLX) Price Target Cut to $112.00 by Analysts at Deutsche Bank Aktiengesellschaft

Clorox (NYSE:CLX) had its target price lowered by analysts at Deutsche Bank Aktiengesellschaft from $114.00 to $112.00 in a research report issued on Wednesday,MarketScreener reports. The firm currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target indicates a potential downside of 4.44% from the stock’s current price.

Other equities analysts have also issued research reports about the stock. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating on the stock in a report on Friday, January 16th. BNP Paribas Exane lowered their target price on Clorox from $103.00 to $101.00 and set an “underperform” rating for the company in a report on Friday, January 16th. Bank of America reduced their target price on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Friday, January 9th. Finally, Wells Fargo & Company boosted their target price on Clorox from $108.00 to $115.00 and gave the stock an “equal weight” rating in a report on Friday, January 23rd. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and an average price target of $118.67.

Clorox Price Performance

Clorox stock traded up $2.23 during mid-day trading on Wednesday, reaching $117.21. The company had a trading volume of 523,294 shares, compared to its average volume of 2,218,748. Clorox has a 1 year low of $96.66 and a 1 year high of $159.04. The company has a market capitalization of $14.30 billion, a P/E ratio of 18.42, a P/E/G ratio of 0.56 and a beta of 0.59. The stock’s 50-day simple moving average is $105.19 and its 200-day simple moving average is $113.96. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 11.68% and a return on equity of 358.39%. Clorox’s quarterly revenue was down .8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.55 EPS. On average, equities analysts predict that Clorox will post 7.15 EPS for the current year.

Insider Buying and Selling

In other news, Director Pierre R. Breber purchased 4,000 shares of the company’s stock in a transaction on Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

A number of large investors have recently bought and sold shares of the company. Invesco Ltd. lifted its position in shares of Clorox by 138.3% during the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after buying an additional 1,883,465 shares during the last quarter. Norges Bank bought a new stake in Clorox in the second quarter worth approximately $190,429,000. Van ECK Associates Corp raised its holdings in shares of Clorox by 93.9% during the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in shares of Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock valued at $149,983,000 after buying an additional 856,873 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new position in shares of Clorox during the second quarter valued at approximately $71,856,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Revenue slightly topped Street expectations and operating cash flow showed improvement versus a year ago, giving some near-term fundamental support. Clorox Company (CLX) Stock Falls on Q2 2026 Earnings
• Positive Sentiment: Bullish write-ups argue valuation (forward P/E ~18) and dividend yield make CLX attractive for income investors if management can stabilize volumes and margins. The Clorox Company (CLX): A Bull Case Theory
• Neutral Sentiment: Management hosted its Q2 earnings call and confirmed its outlook; read the transcript for detail on pricing, cost actions and working-capital plans. Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Company press release reiterated results and the outlook — confirmation reduces surprise risk but left execution questions. Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook
• Negative Sentiment: Adjusted EPS missed consensus ($1.39 vs. ~$1.43), driven by higher costs and weaker volume in core cleaning categories — a clear short-term headwind for the share price. Clorox misses quarterly profit estimates
• Negative Sentiment: Management warned of an inventory reset in 2026 that could squeeze profits further — this forward-looking risk is a significant reason for near-term caution. Clorox Faces Profit Squeeze From Inventory Reset In 2026
• Negative Sentiment: Analysts and media highlighted muted demand and shoppers trading down to cheaper alternatives; some shops have cut targets and at least one major firm has an underweight view — pressure on consensus estimates may persist. Clorox Posts Lower Profit on Sales Volume Declines

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.